Low Density Lipoprotein (LDL) News and Research

RSS

Bad cholesterol and high blood pressure may be associated with higher risk of cardiovascular disease

High levels of lipoprotein(a), a type of "bad" cholesterol, may be associated with an 18-20% higher risk of cardiovascular disease among people who have hypertension, however, CVD risk was not higher among those without hypertension, according to new research published today in Hypertension, an American Heart Association journal.

13 Dec 2022

Very low-calorie and vegan diets improve glycemic control in type 2 diabetes

Very low-calorie diets and vegan diets improve weight loss and anthropometric markers in type 2 diabetes patients.

1 Dec 2022

Moderate alcohol intake may affect lipoprotein metabolism

A recent Nutrients journal study evaluated the impact of 1-2 drinks of alcohol per day on cardiovascular biomarkers in the cross-over intervention, prospective, and assessor-blinded trial called the Metabolic Imprints of Alcoholic Beverages (MetAl).

30 Nov 2022

Dietary supplements taken for 'heart health' unlikely to offer meaningful impact on cholesterol levels

Six widely used dietary supplements promoted for improving heart health did not effectively lower LDL or "bad" cholesterol in comparison to a common low-dose statin medication or placebo, according to late breaking science results presented today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

New medication lowers triglyceride levels, yet does not decrease cardiovascular risk in people with Type 2 diabetes

A new medication, pemafibrate, lowered triglyceride levels among adults with Type 2 diabetes yet did not decrease their cardiovascular risk, according to late-breaking science research presented today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

Rosuvastatin vastly superior to six common heart health supplements

Six widely used dietary supplements often advertised to promote heart health are actually ineffective at lowering cholesterol levels.

7 Nov 2022

Weekly weight loss drug reduces BMI in teens

Researchers report that a weekly dose of semaglutide led to a significant BMI reduction in adolescents.

3 Nov 2022

Cardiovascular disease risk factors are largely the same for men and women

For men and women, the risk factors for cardiovascular disease are largely the same, an extensive global study involving University of Gothenburg researchers shows.

17 Oct 2022

Cardiovascular disease risk factors are largely the same for women and men, study shows

For women and men, the risk factors for cardiovascular disease are largely the same, an extensive global study involving University of Gothenburg shows.

21 Sep 2022

Exploring the muscle symptoms associated with statin therapy

In a new study, investigators explored the influences of statin treatment on muscle symptoms.

31 Aug 2022

Review of natural products with promising anti-SARS-CoV-2 potential

In a new study, researchers reviewed existing literature on naturally active products with therapeutic efficacy against SARS-CoV-2.

10 Aug 2022

Tannins as therapeutic agents against SARS-CoV-2

Researchers reviewed tannins as therapeutic agents against SARS-CoV-2.

29 Jul 2022

Lipids in breastmilk may protect against metabolic disease later in life

A new study examines the lipid content in breastmilk and its association with NCDs later in life.

13 Jul 2022

Analysis finds little proof that testosterone treatment increases the risk of cardiovascular events

Testosterone replacement therapy appears safe in the short-to-medium term to treat a condition caused by deficiency of the male sex hormone, according to the most comprehensive analysis of the treatment to date, published in The Lancet Healthy Longevity journal.

9 Jun 2022

Health screening and genetic tests may help detect people who carry a gene for familial hypercholesterolemia

Health screening and genetic tests might identify more than 1 million U.S. adults who carry a gene for familial hypercholesterolemia, a common genetic disorder that causes elevated low-density lipoprotein (LDL) cholesterol, known as "bad cholesterol," which may lead to premature heart attack or death, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

18 May 2022

Low Density Lipoprotein (LDL) News and Research

Bad cholesterol and high blood pressure may be associated with higher risk of cardiovascular disease

Very low-calorie and vegan diets improve glycemic control in type 2 diabetes

Moderate alcohol intake may affect lipoprotein metabolism

Dietary supplements taken for 'heart health' unlikely to offer meaningful impact on cholesterol levels

New medication lowers triglyceride levels, yet does not decrease cardiovascular risk in people with Type 2 diabetes

Rosuvastatin vastly superior to six common heart health supplements

Weekly weight loss drug reduces BMI in teens

Cardiovascular disease risk factors are largely the same for men and women

Cardiovascular disease risk factors are largely the same for women and men, study shows

Exploring the muscle symptoms associated with statin therapy

Review of natural products with promising anti-SARS-CoV-2 potential

Tannins as therapeutic agents against SARS-CoV-2

Lipids in breastmilk may protect against metabolic disease later in life

Analysis finds little proof that testosterone treatment increases the risk of cardiovascular events

Health screening and genetic tests may help detect people who carry a gene for familial hypercholesterolemia

The potential role of the gut microbiome in modifying patient responses to statin therapy

Effect of vegetarian food intake on nutritional status and growth of young children

Aspirin for non-obstructive coronary artery disease does not reduce major cardiovascular events

Expanding statin prescription could be a cost-effective intervention against cardiovascular disease

Insomnia common in heart disease patients and linked with subsequent cardiovascular events

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News